Dong-A Socio Holdings Co., Ltd. (000640) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dong-A Socio Holdings Co., Ltd. (000640:KRX), powered by AI.

Current Price
₩95,000
P/E Ratio
10.5
Market Cap
621.0B
Sector
Healthcare
What is the Dong-A Socio Holdings Co., Ltd. stock price forecast?

Dong-A Socio Holdings Co., Ltd. is currently trading at ₩95,000. View real-time AI analysis on Alpha Lenz.

What is Dong-A Socio Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Dong-A Socio Holdings Co., Ltd. on Alpha Lenz.

What is Dong-A Socio Holdings Co., Ltd.'s P/E ratio?

Dong-A Socio Holdings Co., Ltd.'s P/E ratio is 10.5.

Dong-A Socio Holdings Co., Ltd.

KRX · 000640
₩95,000
Ask about Dong-A Socio Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Dong-A Socio Holdings Co., Ltd. trades at a P/E of 10.5 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 14.8% highlights clear growth momentum.

Ask for details

Company Overview

Dong-A Socio Holdings Co., Ltd. is a prominent holding company in South Korea, primarily focusing on pharmaceutical development, healthcare, and related sectors. As a holding entity, its main purpose is to oversee and manage a portfolio of subsidiaries that are involved in various stages of drug development, production, and distribution. Dong-A Socio Holdings plays a critical role in the pharmaceutical industry, engaging in research to advance medical breakthroughs and improve healthcare outcomes. With diversified interests that also span consumer healthcare products and biotechnology, the company underscores its commitment to addressing a wide array of health-related needs. In the financial market, Dong-A Socio Holdings serves as a key participant in South Korea's economic landscape by fostering innovation within the healthcare sector and contributing to the overall growth of the pharmaceutical industry. This positioning not only strengthens its market presence but also enhances its influence in shaping health-related policies and practices.

CEO김민영
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees83

Company Statistics

FY 2024

Profile

₩620,961,230,000Market Cap
₩1,333,229,636,660Revenue
6.54MShares Out
83Employees

Margins

30.61%Gross
15.74%EBITDA
6.16%Operating
5.73%Pre-Tax
4.32%Net

Valuation

10.54P/E
0.58P/B
0.46EV/Sales
5.95EV/EBITDA
82.36P/FCF

Growth (CAGR)

14.77%Rev 3Yr
11.61%Rev 5Yr
10.07%Op Inc 3Yr
9.22%Op Inc 5Yr
-1.65%Net Inc 3Yr
23.58%Net Inc 5Yr

Returns

2.89%ROA
5.63%ROE
5.30%ROIC

Financial Health

₩117,391,058,230Cash & Cash Equivalents
₩849,155,258,500Net Debt
90.85%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Dong-A Socio Holdings Co., Ltd. trades at a P/E of 10.5 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 14.8% highlights clear growth momentum.

Ask for details

Frequently Asked Questions

Dong-A Socio Holdings Co., Ltd. (ticker: 000640) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 83 employees. Market cap is $621.0B.

The current price is ₩95,000 with a P/E ratio of 10.54x and P/B of 0.58x.

ROE is 5.63% and operating margin is 6.16%. Annual revenue is $1.3T.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Dong-A Socio Holdings Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩95,000 | Alpha Lenz